Literature DB >> 4389065

A critical evaluation of three methods for the study of adrenergic beta-blocking and anti-arrhythmic agents.

B Vargaftig, J L Coignet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4389065     DOI： 10.1016/0014-2999(69)90064-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  7 in total

1.  A potent new beta2-adrenoceptor blocking agent.

Authors:  J L Imbs; F Miesch; J Schwartz; J Velly; G Leclerc; A Mann; C G Wermuth
Journal:  Br J Pharmacol       Date:  1977-07       Impact factor: 8.739

2.  LG 6-101 and LG 6-102, two new propafenone-related antiarrhythmic agents with good oral activity in rats.

Authors:  T C Wascher; P Dittrich; W R Kukovetz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

3.  Local anaesthetic and antiarrhythmic properties of an aminosteroid: 3alpha-dimethyl-amino-5alpha-androstan-2beta-ol-17-one (Org. NA 13).

Authors:  W R Buckett; F A Marwick
Journal:  Br J Pharmacol       Date:  1975-05       Impact factor: 8.739

4.  Electrophysiological properties of phentolamine in man.

Authors:  L Gould; C V Reddy; W Chua; C R Swamy; J C Dorismond
Journal:  Br Heart J       Date:  1977-09

5.  Actions of antiarrhythmic drugs on refractory period and contractility of isolated rat and guinea-pig atria.

Authors:  G Zetler; O Strubelt
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

6.  Evaluation of antagonism of aconitine-induced dysrhythmias in mice as a method of detecting and assessing antidysrhythmic activity.

Authors:  E Winslow
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

7.  Class I and III antiarrhythmic actions of prazosin in guinea-pig papillary muscles.

Authors:  O Pérez; C Valenzuela; E Delpón; J Tamargo
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.